Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

Andrew S. Chi, Rohinton S. Tarapore, Matthew D. Hall, Nicole Shonka, Sharon Gardner, Yoshie Umemura, Ashley Sumrall, Ziad Khatib, Sabine Mueller, Cassie Kline, Wafik Zaky, Soumen Khatua, Shiao Pei Weathers, Yazmin Odia, Toba N. Niazi, Doured Daghistani, Irene Cherrick, David Korones, Matthias A. Karajannis, Xiao Tang KongJane Minturn, Angela Waanders, Isabel Arillaga-Romany, Tracy Batchelor, Patrick Y. Wen, Krystal Merdinger, Lee Schalop, Martin Stogniew, Joshua E. Allen, Wolfgang Oster, Minesh P. Mehta*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201'. Together they form a unique fingerprint.

Medicine & Life Sciences